| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |